Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
DTRMWXHS-12 inhibits BTK, resulting in decreased B-cell receptor (BCR) signaling and potentially leading to reduced tumor cell growth (NCI Drug Dictionary).
|DrugClasses||BTK inhibitor 33|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|DTRMWXHS-12 + Everolimus||DTRMWXHS-12 Everolimus||0||1|
|DTRMWXHS-12 + Everolimus + Pomalidomide||DTRMWXHS-12 Everolimus Pomalidomide||0||2|